Throughout December xxxx, the price of Amphotericin B, a vital antifungal drug, experienced a notable increase in the United States, fueled by growing demand from end-users and various global market factors. In response to these market shifts, pharmaceutical companies, distributors, and wholesalers adjusted their pricing strategies, raising their margins to capitalize on the favorable conditions.
The rising cases of Valley fever in California, along with its spread to other regions such as Arizona, Nevada, New Mexico, Utah, Texas, and parts of Mexico and Central and South America, significantly contributed to the increase of Amphotericin B prices in the United States. By the close of the month, the Amphotericin B price had risen by around x.xxx, reaching xxx,xxx per metric ton on a CFR Houston basis. Valley fever is a fungal lung infection caused by Coccidioides, and as the number of cases surged,...
